Notably, the combined loss of NACC1 and FKBP10 further decreased tumor growth (by 52.8%) in immune-competent but not immune-compromised mice, again without altering cell growth in vitro (Fig. 6, A to D). The gene discussed is NACC1; the disease is neoplasm.